A review of antioxidants and Alzheimer's disease.
暂无分享,去创建一个
[1] M. Mulero,et al. Aluminum‐induced pro‐oxidant effects in rats: protective role of exogenous melatonin , 2003, Journal of pineal research.
[2] B. Ames,et al. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: Partial reversal by feeding acetyl-l-carnitine and/or R-α-lipoic acid , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[3] D. Ashline,et al. Homocysteine potentiates β‐amyloid neurotoxicity: role of oxidative stress , 2001 .
[4] R. Reiter,et al. An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease , 2000, Journal of Neural Transmission.
[5] Bing-sheng Li,et al. α-lipoic acid protects rat cortical neurons against cell death induced by amyloid and hydrogen peroxide through the Akt signalling pathway , 2001, Neuroscience Letters.
[6] S. Nah,et al. Protective effect of ginsenosides, active ingredients of Panax ginseng, on kainic acid-induced neurotoxicity in rat hippocampus , 2002, Neuroscience Letters.
[7] G. M. Cole,et al. Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology , 2001, Neurobiology of Aging.
[8] C. P. Maurizi. Alzheimer's disease: roles for mitochondrial damage, the hydroxyl radical, and cerebrospinal fluid deficiency of melatonin. , 2001, Medical hypotheses.
[9] S. Kulkarni,et al. Possible antioxidant mechanism in melatonin reversal of aging and chronic ethanol-induced amnesia in plus-maze and passive avoidance memory tasks. , 2001, Free radical biology & medicine.
[10] E. Cho,et al. Ginsenoside‐Rd attenuates oxidative damage related to aging in senescence‐accelerated mice , 2004, The Journal of pharmacy and pharmacology.
[11] S. Mandel,et al. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. , 2002, Biochemical pharmacology.
[12] J. Joseph,et al. A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. , 2001, Free radical biology & medicine.
[13] J. Mix,et al. A double‐blind, placebo‐controlled, randomized trial of Ginkgo biloba extract EGb 761® in a sample of cognitively intact older adults: neuropsychological findings , 2002, Human psychopharmacology.
[14] J. Pettegrew,et al. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression , 2000, Molecular Psychiatry.
[15] N. P. Kedar. Can we prevent Parkinson's and Alzheimer's disease? , 2003, Journal of postgraduate medicine.
[16] Y. Christen,et al. Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts , 2004, Neurobiology of Disease.
[17] Y. Gupta,et al. Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. , 2002, Life sciences.
[18] Taeck-Hyun Lee,et al. Effect of ginseng radix on c-Fos expression in the hippocampus of streptozotocin-induced diabetic rats. , 2003, Journal of pharmacological sciences.
[19] P. Schultz,et al. Age-related effects of Ginkgo biloba extract on synaptic plasticity and excitability , 2004, Neurobiology of Aging.
[20] A. Hofman,et al. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. , 2004, Archives of neurology.
[21] T. Sasaoka,et al. Antioxidant effects of tetrahydro‐β‐carboline derivatives identified in aged garlic extract , 2002, BioFactors.
[22] I. Bourdel-Marchasson,et al. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. , 2001, Age and ageing.
[23] R. Quirion,et al. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide‐related toxicity in cultured hippocampal neurons , 2000, British journal of pharmacology.
[24] P. Knipschild,et al. The Efficacy of Ginkgo for Elderly People with Dementia and Age‐Associated Memory Impairment: New Results of a Randomized Clinical Trial , 2000, Journal of the American Geriatrics Society.
[25] P. Agostinho,et al. Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide , 2003, Neuroscience Research.
[26] K. Davies,et al. Mitochondrial free radical generation, oxidative stress, and aging. , 2000, Free radical biology & medicine.
[27] L. Thal,et al. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease , 2003, International clinical psychopharmacology.
[28] I. Young,et al. Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease. , 1999, QJM : monthly journal of the Association of Physicians.
[29] Debomoy K Lahiri,et al. Dietary supplementation with melatonin reduces levels of amyloid beta‐peptides in the murine cerebral cortex , 2004, Journal of pineal research.
[30] Deborah Gustafson,et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. , 2004, Archives of neurology.
[31] R. Reiter,et al. Melatonin and mitochondrial function. , 2004, Life sciences.
[32] H. Gertz,et al. Review about Ginkgo biloba special extract EGb 761 (Ginkgo). , 2003, Current pharmaceutical design.
[33] M. Trabucchi,et al. Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors. , 2003, Current medical research and opinion.
[34] Koji Abe,et al. Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease , 2003, Journal of neurochemistry.
[35] J. Muñoz-Castañeda,et al. Comparison of melatonin versus vitamin C on oxidative stress and antioxidant enzyme activity in Alzheimer's disease induced by okadaic acid in neuroblastoma cells. , 2002, European journal of pharmacology.
[36] Q. Peng,et al. Neuroprotective effect of garlic compounds in amyloid-beta peptide-induced apoptosis in vitro. , 2002, Medical science monitor : international medical journal of experimental and clinical research.
[37] A. Sachinidis,et al. Molecular mechanisms explaining the preventive effects of catechins on the development of proliferative diseases. , 2004, Current pharmaceutical design.
[38] R. Quirion,et al. EGb 761 is a neuroprotective agent against beta-amyloid toxicity. , 2002, Cellular and molecular biology.
[39] Y. Christen,et al. What is Ginkgo biloba extract EGb 761? An overview--from molecular biology to clinical medicine. , 2002, Cellular and molecular biology.
[40] X. Tang,et al. Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats. , 2000, European journal of pharmacology.
[41] E. Kapaki,et al. Ascorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease , 1997, Acta neurologica Scandinavica.
[42] F. V. Defeudis,et al. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. , 2000, Current drug targets.
[43] Antioxidants in Alzheimer's disease-vitamin C delivery to a demanding brain. , 2003, Journal of Alzheimer's disease : JAD.
[44] G. Taglialatela,et al. Ascorbic acid prevents β-amyloid-induced intracellular calcium increase and cell death in PC12 cells , 1998, Neuroscience Letters.
[45] Y. Gupta,et al. Effect of alpha lipoic acid on intracerebroventricular streptozotocin model of cognitive impairment in rats , 2003, European Neuropsychopharmacology.
[46] N. Nishiyama,et al. Ameliorative effect of S-allylcysteine, a major thioallyl constituent in aged garlic extract, on learning deficits in senescence-accelerated mice. , 2001, The Journal of nutrition.
[47] B. Vellas,et al. Low plasma vitamin C in Alzheimer patients despite an adequate diet , 1998, International journal of geriatric psychiatry.
[48] S. Sorbi,et al. Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients. , 2002, Free radical biology & medicine.
[49] Yukui Zhang,et al. Melatonin in Chinese medicinal herbs. , 2003, Life sciences.
[50] D. Foley,et al. Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study. , 2004, American journal of epidemiology.
[51] S. Suh,et al. Protective effect of green tea polyphenol (‐)‐epigallocatechin gallate and other antioxidants on lipid peroxidation in gerbil brain homogenates , 2003, Phytotherapy research : PTR.
[52] L. Beckett,et al. Vitamin E and Vitamin C Supplement Use and Risk of Incident Alzheimer Disease , 1998, Alzheimer disease and associated disorders.
[53] Y. Surh,et al. Effects of Selected Ginsenosides on Phorbol Ester‐Induced Expression of Cyclooxygenase‐2 and Activation of NF‐κB and ERK1/2 in Mouse Skin , 2002, Annals of the New York Academy of Sciences.
[54] L. Thal,et al. A 1-year controlled trial of acetyl-l-carnitine in early-onset AD , 2000, Neurology.
[55] V. Caso,et al. The Action of Acetyl‐l‐Carnitine on the Neurotoxicity Evoked by Amyloid Fragments and Peroxide on Primary Rat Cortical Neurones , 2001, Annals of the New York Academy of Sciences.
[56] J. Cai,et al. Improving effects of huperzine A on spatial working memory in aged monkeys and young adult monkeys with experimental cognitive impairment. , 1999, The Journal of pharmacology and experimental therapeutics.
[57] R. W. Gracy,et al. Vitamin E prevents oxidation of antiapoptotic proteins in neuronal cells , 2003, Proteomics.
[58] R. Martins,et al. Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants. , 2003, Free radical biology & medicine.
[59] Peter P. Zandi,et al. Apolipoprotein E ϵ4 Count Affects Age at Onset of Alzheimer Disease,but Not Lifetime Susceptibility: The Cache County Study , 2004 .
[60] T. Shea,et al. Acetyl-l-Carnitine Protects Against Amyloid-Beta Neurotoxicity: Roles of Oxidative Buffering and ATP Levels , 2002, Neurochemical Research.
[61] D. Ruff,et al. Effect of Aged Garlic Extract on Caspase-3 Activity, In Vitro , 2002, Nutritional neuroscience.
[62] L. Murphy,et al. Ginseng, Sex Behavior, and Nitric Oxide , 2002, Annals of the New York Academy of Sciences.
[63] J. Richardson,et al. Mitochondria from Alzheimer's fibroblasts show decreased uptake of calcium and increased sensitivity to free radicals. , 1994, Life sciences.
[64] D. Mckenna,et al. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. , 2001, Alternative therapies in health and medicine.
[65] Jian Yang,et al. Huperzine A protects rat pheochromocytoma cells against hydrogen peroxide-induced injury , 1999, Neuroscience Letters.
[66] T Seal,et al. Screening of antioxidant activity of three Indian medicinal plants, traditionally used for the management of neurodegenerative diseases. , 2003, Journal of ethnopharmacology.
[67] K. Kannan,et al. Oxidative stress and apoptosis. , 2000, Pathophysiology : the official journal of the International Society for Pathophysiology.
[68] M. Altamirano-Lozano,et al. Total antioxidant levels, gender, and age as risk factors for DNA damage in lymphocytes of the elderly , 2001, Mechanisms of Ageing and Development.
[69] P. Mecocci. Oxidative stress in mild cognitive impairment and Alzheimer disease: a continuum. , 2004, Journal of Alzheimer's disease : JAD.
[70] A. Wirz-Justice,et al. Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's disease , 2001, Neuroscience Letters.
[71] H. Zhang,et al. Huperzine A attenuates amyloid β‐peptide fragment 25‐35‐induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase‐3 activation , 2002, Journal of neuroscience research.
[72] G. Cole,et al. The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse , 2001, The Journal of Neuroscience.
[73] Simon Melov,et al. Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice , 2003, Journal of neurochemistry.
[74] R. K. Gordon,et al. The NMDA receptor ion channel: a site for binding of huperzine A , 2001, Journal of applied toxicology : JAT.
[75] R. Acquaviva,et al. Nitric oxide-related toxicity in cultured astrocytes: effect of Bacopa monniera. , 2003, Life sciences.
[76] L. Thal,et al. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. , 2003, Sleep.
[77] Y. Sagara,et al. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. , 2001, Free radical biology & medicine.
[78] S. K. Ghosal,et al. Antioxidant activity ofBacopa monniera in rat frontal cortex, striatum and hippocampus , 2000, Phytotherapy research : PTR.
[79] E. Esposito,et al. Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. , 2003, Current drug targets. CNS and neurological disorders.
[80] Xiongwei Zhu,et al. Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. , 2004, Journal of Alzheimer's disease : JAD.
[81] W. D. Ehmann,et al. Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. , 1998, Neurotoxicology.
[82] E. Melamed,et al. Antioxidant treatment in alzheimer’s disease , 2003, Journal of Molecular Neuroscience.
[83] D. Bai,et al. Stereoselectivities of enantiomers of huperzine A in protection against β-amyloid25–35-induced injury in PC12 and NG108-15 cells and cholinesterase inhibition in mice , 2002, Neuroscience Letters.
[84] K. Bae,et al. Green tea catechins as a BACE1 (β-secretase) inhibitor , 2003 .
[85] D. Butterfield,et al. The antioxidants α‐lipoic acid and N‐acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice , 2003, Journal of neurochemistry.
[86] P. Mecocci,et al. Short-term and long-term vitamin C supplementation in humans dose-dependently increases the resistance of plasma to ex vivo lipid peroxidation. , 2004, Archives of biochemistry and biophysics.
[87] B. Halliwell,et al. Increased iron staining in the cerebral cortex of cholesterol fed rabbits , 2004, Mechanisms of Ageing and Development.
[88] S. Suh,et al. The green tea polyphenol (−)-epigallocatechin gallate attenuates β-amyloid-induced neurotoxicity in cultured hippocampal neurons , 2001 .
[89] D. Bai,et al. Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease. , 2000, Current medicinal chemistry.
[90] P. Arivazhagan,et al. Neurochemical changes related to ageing in the rat brain and the effect of dl-α-lipoic acid , 2002, Experimental Gerontology.
[91] W. Markesbery,et al. Protection against amyloid beta peptide and iron/hydrogen peroxide toxicity by alpha lipoic acid. , 2003, Journal of Alzheimer's disease : JAD.
[92] J. Sastre,et al. Mitochondrial theory of aging: importance to explain why females live longer than males. , 2003, Antioxidants & redox signaling.
[93] T. Montine,et al. Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease. , 2004, Journal of Alzheimer's disease : JAD.
[94] K. Hall,et al. Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. , 1999, American journal of epidemiology.
[95] J. Yesavage,et al. Acetyl L-Carnitine Slows Decline in Younger Patients With Alzheimer's Disease: A Reanalysis of a Double-Blind, Placebo-Controlled Study Using the Trilinear Approach , 1998, International Psychogeriatrics.
[96] S. Arlt,et al. Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease. , 2001, Free radical biology & medicine.
[97] K. Hensley,et al. Reactive oxygen species and protein oxidation in aging: a look back, a look ahead. , 2002, Archives of biochemistry and biophysics.
[98] Y. Naito,et al. Ginkgo biloba leaf extract: review of biological actions and clinical applications. , 1999, Antioxidants & redox signaling.
[99] Y. Surh,et al. Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death ☆ , 2003 .
[100] F. J. Romero,et al. Lipid peroxidation products and antioxidants in human disease. , 1998, Environmental health perspectives.
[101] S. Maxwell,et al. Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia , 1998, International journal of geriatric psychiatry.
[102] D. Butterfield,et al. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. , 2000, Journal of structural biology.
[103] J. Trojanowski,et al. Early Vitamin E supplementation in young but not aged mice reduces Aβ levels and amyloid deposition in a transgenic model of Alzheimer's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[104] T. Tsuneyoshi,et al. Isolation and characterization of the genes up-regulated in isolated neurons by aged garlic extract (AGE). , 2001, The Journal of nutrition.
[105] D. Butterfield,et al. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: A nutritional approach , 2003, Amino Acids.
[106] Vijayalaxmi,et al. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. , 2004, Polish journal of pharmacology.
[107] A. Tappel,et al. Oxidant free radical initiated chain polymerization of protein and other biomolecules and its relationship to diseases. , 2004, Medical hypotheses.
[108] Kuresh Youdim,et al. Roles of vitamins E and C on neurodegenerative diseases and cognitive performance. , 2002, Nutrition reviews.
[109] H. Steinbusch,et al. Antioxidants and Alzheimer's disease: from bench to bedside (and back again) , 2002, Current opinion in clinical nutrition and metabolic care.
[110] S. Shiu,et al. The effects of melatonin and Ginkgo biloba extract on memory loss and choline acetyltransferase activities in the brain of rats infused intracerebroventricularly with beta-amyloid 1-40. , 2002, Life sciences.
[111] C Eisdorfer,et al. Music therapy increases serum melatonin levels in patients with Alzheimer's disease. , 1999, Alternative therapies in health and medicine.
[112] M. Polidori. Antioxidant micronutrients in the prevention of age-related diseases. , 2003, Journal of postgraduate medicine.
[113] P. Barberger‐Gateau,et al. Association between antioxidant nutritional indicators and the incidence of dementia: results from the PAQUID prospective cohort study , 2003, European Journal of Clinical Nutrition.
[114] M. Hüll,et al. Synergistic inhibitory effect of ascorbic acid and acetylsalicylic acid on prostaglandin E2 release in primary rat microglia , 2003, Journal of neurochemistry.
[115] X. Tang,et al. Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein-(1-40) in rat. , 2001, European journal of pharmacology.
[116] A. Hofman,et al. Dietary Intake of Antioxidants and Risk of Alzheimer Disease , 2002 .
[117] A. Raina,et al. Homocysteine and Alzheimer's disease: a modifiable risk? , 2004, Free radical biology & medicine.
[118] N. Delibaş,et al. Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: cross-sectional study. , 2002, Croatian medical journal.
[119] B. Harrison,et al. Effects of a combined extract of Ginkgo biloba and Bacopa monniera on cognitive function in healthy humans , 2004, Human psychopharmacology.
[120] Zhenxin Zhang,et al. [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial]. , 2002, Zhonghua yi xue za zhi.
[121] K. Prasad,et al. Risk Factors for Alzheimer’s Disease: Role of Multiple Antioxidants, Non-Steroidal Anti-inflammatory and Cholinergic Agents Alone or in Combination in Prevention and Treatment , 2002, Journal of the American College of Nutrition.
[122] K. Charlton,et al. Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients. , 2004, The journal of nutrition, health & aging.
[123] M. Beal. Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.
[124] Brian J Bacskai,et al. In Vivo Imaging of Reactive Oxygen Species Specifically Associated with Thioflavine S-Positive Amyloid Plaques by Multiphoton Microscopy , 2003, The Journal of Neuroscience.
[125] M. Parle,et al. Ascorbic Acid: a promising memory-enhancer in mice. , 2003, Journal of pharmacological sciences.
[126] V. Solfrizzi,et al. The role of diet in cognitive decline , 2003, Journal of Neural Transmission.
[127] J. Hong,et al. A double-blind crossover study evaluating the efficacy of korean red ginseng in patients with erectile dysfunction: a preliminary report. , 2002, The Journal of urology.
[128] M. di Luca,et al. Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzhelmer's disease. , 2002, Cellular and molecular biology.
[129] K. Prasad,et al. Multiple antioxidants in the prevention and treatment of Alzheimer disease: analysis of biologic rationale. , 2000, Clinical neuropharmacology.
[130] B. Halliwell,et al. Iron, Atherosclerosis, and Neurodegeneration: A Key Role for Cholesterol in Promoting Iron‐Dependent Oxidative Damage? , 2004, Annals of the New York Academy of Sciences.
[131] P. Mecocci,et al. Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. , 2002, Journal of Alzheimer's disease : JAD.
[132] Sonia Trombino,et al. Antioxidant effect of ferulic acid in isolated membranes and intact cells: synergistic interactions with alpha-tocopherol, beta-carotene, and ascorbic acid. , 2004, Journal of agricultural and food chemistry.
[133] Satoru Kobayashi,et al. Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine , 2002, Journal of neuroscience research.
[134] B. Winblad,et al. An active and socially integrated lifestyle in late life might protect against dementia , 2004, The Lancet Neurology.
[135] C. Shults. Coenzyme Q10 in neurodegenerative diseases. , 2003, Current medicinal chemistry.
[136] A John,et al. Differential modulation of growth and glutathione metabolism in cultured rat astrocytes by 4-hydroxynonenal and green tea polyphenol, epigallocatechin-3-gallate. , 2002, Neurotoxicology.
[137] P. Shah,et al. Differential Effects of Green Tea–Derived Catechin on Developing Versus Established Atherosclerosis in Apolipoprotein E–Null Mice , 2004, Circulation.
[138] P. Knipschild,et al. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. , 2003, Journal of clinical epidemiology.
[139] V. Adhami,et al. Antioxidants of the beverage tea in promotion of human health. , 2004, Antioxidants & redox signaling.
[140] C. Borek,et al. Antioxidant health effects of aged garlic extract. , 2001, The Journal of nutrition.
[141] F. Lezoualc’h,et al. N‐acetyl‐serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF‐κB , 1998, Journal of pineal research.
[142] P. Zandi,et al. Dementia: The leading predictor of death in a defined elderly population , 2004, Neurology.
[143] J. V. Smith,et al. Studies on molecular mechanisms of Ginkgo biloba extract , 2004, Applied Microbiology and Biotechnology.
[144] F. Clostre. [Ginkgo biloba extract (EGb 761). State of knowledge in the dawn of the year 2000]. , 1999, Annales pharmaceutiques francaises.
[145] A. Klugman,et al. Alpha lipoic acid for dementia. , 2004, The Cochrane database of systematic reviews.
[146] Amitava Das,et al. A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba Anticholinesterase and cognitive enhancing activities , 2002, Pharmacology Biochemistry and Behavior.
[147] A. Takashima,et al. Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease , 2003, Journal of neurochemistry.
[148] H. Arai,et al. [A new interventional strategy for Alzheimer's disease by Japanese herbal medicine]. , 2000, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.
[149] R. Mayeux,et al. Antioxidant vitamin intake and risk of Alzheimer disease. , 2003, Archives of neurology.
[150] R. Ravid,et al. Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. , 2003, The Journal of clinical endocrinology and metabolism.
[151] M. Grundman,et al. Antioxidant strategies for Alzheimer's disease , 2002, Proceedings of the Nutrition Society.
[152] G. Perry,et al. Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease. , 2004, Acta neurobiologiae experimentalis.
[153] S. Mandel,et al. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐gallate: implications for neurodegenerative diseases , 2004 .
[154] P. Doraiswamy. Non-cholinergic strategies for treating and preventing Alzheimer's disease. , 2002, CNS drugs.
[155] R. Bolli,et al. New perspectives on vitamin E: γ-tocopherol and carboxyethylhydroxychroman metabolites in biology and medicine , 2004 .
[156] E. Seifritz,et al. Red Wine Ingredient Resveratrol Protects from β-Amyloid Neurotoxicity , 2003, Gerontology.
[157] J. Miquel,et al. The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. , 2002, Archives of gerontology and geriatrics.
[158] G. Perry,et al. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. , 2000, Antioxidants & redox signaling.
[159] J. Saver,et al. Combination Therapies and the Theoretical Limits of Evidence-Based Medicine , 2001, Neuroepidemiology.
[160] V. Srinivasan. Melatonin oxidative stress and neurodegenerative diseases. , 2002, Indian journal of experimental biology.
[161] R. W. Gracy,et al. Reactive oxygen species: the unavoidable environmental insult? , 1999, Mutation research.
[162] N. Chainani-Wu. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). , 2003, Journal of alternative and complementary medicine.
[163] D. Butterfield,et al. Vitamin E Prevents Alzheimer's Amyloid beta-Peptide (1-42)-Induced Neuronal Protein Oxidation and Reactive Oxygen Species Production. , 2000, Journal of Alzheimer's disease : JAD.
[164] H. Singh,et al. Adaptogenic effect of Bacopa monniera (Brahmi) , 2003, Pharmacology Biochemistry and Behavior.
[165] P. Riederer,et al. Alpha-lipoic acid as a new treatment option for Alzheimer [corrected] type dementia. , 2001, Archives of gerontology and geriatrics.
[166] Kohan,et al. Peripheral markers of oxidative stress in probable Alzheimer patients , 1999, European journal of clinical investigation.
[167] Andrew Jenner,et al. Characterization of antioxidant and antiglycation properties and isolation of active ingredients from traditional chinese medicines. , 2004, Free radical biology & medicine.
[168] P. Mecocci,et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease , 2003, Neurobiology of Aging.
[169] Kenjiro Ono,et al. Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro , 2004, Journal of neuroscience research.
[170] S. Kanowski,et al. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. , 2003, Pharmacopsychiatry.
[171] H. Buschke,et al. Leisure activities and the risk of dementia in the elderly. , 2003, The New England journal of medicine.